Patient centred care in centralised radiotherapy services
Research type
Research Study
Full title
The impact of receiving a centralised treatment for primary lung cancer (SABR) on the patient-centredness of care: a qualitative study of patient’s experiences.
IRAS ID
240727
Contact name
Cath Taylor
Contact email
Sponsor organisation
University of Surrey
Duration of Study in the UK
0 years, 9 months, 23 days
Research summary
Stereotactic Ablative Body Radiotherapy (SABR) is a specialist type of radiotherapy treatment, commissioned for patients with inoperable stage one non-small cell lung cancer. This is an aging patient group, with complex needs. Around half of radiotherapy departments in England are commissioned to deliver this treatment, which results in many patients having to access treatment from a radiotherapy department which may not be local to them. This also requires integration of care and between the specialist radiotherapy department and the multidisciplinary team at the patient's local hospital. Although the centralisation of services is designed to ensure fair and equitable access to a treatment that is thought to be more effective, it is not known how this centralisation of care is experienced by patients.
Centralisation of specialist services has previously occurred in the NHS; stroke, neonatal and cardiac.
This is a single centre study and aims to explore patient's experiences and perceptions of patient centred care when recieving SABR for primary lung cancer at a commissioned centre.REC name
North East - York Research Ethics Committee
REC reference
18/NE/0148
Date of REC Opinion
19 Apr 2018
REC opinion
Favourable Opinion